Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation

Abstract Background The risk of ventricular arrhythmias in patients on QT prolonging drugs is indicated to be increased early after cardioversion (CV) of atrial fibrillation (AF) to sinus rhythm (SR). Sotalol, used to prevent AF relapse, prolongs cardiac repolarization and corrected QT interval (QTc...

Full description

Bibliographic Details
Main Authors: Hanna Lenhoff, Börje Darpö, Alex Page, Jean Philippe Couderc, Per Tornvall, Mats Frick
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Annals of Noninvasive Electrocardiology
Subjects:
anti‐arrhythmic
atrial fibrillation
cardioversion
QT interval
sotalol
Online Access:https://doi.org/10.1111/anec.12834

Internet

https://doi.org/10.1111/anec.12834

Similar Items